Hyperlipidaemia
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia (NCT04964557) | AstraZeneca | 2021-07-07 |
| TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) (NCT00328523) | Organon and Co | 2004-06-01 |
Track Hyperlipidaemia automatically
Every clearance here is in the API, with alerts when new ones post.